Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive-Dose Melphalan and Topotecan in Multiple Myeloma
NCT00325416Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Nov 2001
- Primary completion
- Jul 2013
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan liposome in multiple myeloma (MM), sponsored by Moffitt Cancer Center. Started Nov 2001; status: completed.
02
Drugs
topotecan liposome
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00325416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00325416.